Amy L Flaxman

14PUBLICATIONS
90CO-AUTHORS
Gene and molecular therapyInnate immunityRadiation therapyInfectious diseasesMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 13, 2026
Phase I/IIa study to assess the safety, immunogenicity and efficacy of ChAdOx1-MVA vectored vaccines expressing a novel liver-stage malaria dual antigen LS2 by sporozoite challenge in malaria-naïve adults.

Daniel Silman, Amy Flaxman, Mehreen Datoo

|Jan 27, 2026
Phase II multicentre double-blind randomised controlled trial of a Bivalent VaccInation against Salmonella Typhi and Paratyphi A (BiVISTA) using a controlled human infection model of paratyphoid A infection: study protocol.

Margarete Paganotti Vicentine, Naina McCann, Oisin Hennigan

|Feb 02, 2023
Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trials.

Merryn Voysey, Amy Flaxman, Jeremy Aboagye

|Oct 13, 2022
Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection.

Alexander J Mentzer, Daniel O'Connor, Sagida Bibi

|Mar 11, 2022
Divergent trajectories of antiviral memory after SARS-CoV-2 infection.

Adriana Tomic, Donal T Skelly, Ane Ogbe

|Aug 28, 2021
Efficacy and Safety of a Modified Vaccinia Ankara-NP+M1 Vaccine Combined with QIV in People Aged 65 and Older: A Randomised Controlled Clinical Trial (INVICTUS).

Chris Butler, Chris Ellis, Pedro M Folegatti

Pageof 3

Frequent Collaborators

8 joint publications

Katie J Ewer

6 joint publications

Andrew J Pollard

5 joint publications

Pedro M Folegatti

5 joint publications

Sarah Gilbert